UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056565
Receipt number R000064644
Scientific Title Effect of the test food on perception of Emotions.
Date of disclosure of the study information 2025/01/20
Last modified on 2024/12/25 16:35:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of the test food on perception of Emotions.

Acronym

Effect of the test food on perception of Emotions.

Scientific Title

Effect of the test food on perception of Emotions.

Scientific Title:Acronym

Effect of the test food on perception of Emotions.

Region

Japan


Condition

Condition

Healthy participants

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to investigate the effects of continuous intake of test foods for 12 weeks on perception of Emotions of Japanese men and women, aged 20 or more.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

perception of Emotions test (correct response, reaction time)
Electroencephalography

Key secondary outcomes

Shifting attention test (correct response, errors, reaction time)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

12 weeks intake of the test food 1

Interventions/Control_2

12 weeks intake of the placebo food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1) Japanese men and women aged 20 years or more at the time of informed consent
2) Participants who is able to take 9 capsules daily for 2 weeks.
3) Non smoker
4) Participants who has received sufficient explanation of the purpose and content of the research, is capable of giving informed consent, voluntarily volunteers to participate in the research, and consents to participate in the research in writing.

Key exclusion criteria

1) Participants who is currently receiving any medications or outpatient treatment.
2) Participants who is currently doing exercise or diet under the supervision of a doctor
3) Participants who is may develop allergy due to the test food
4) Participants who is drug dependent, present or dependent on alcohol
5) Participantst who is history of psychiatry during hospitalization due to mental disorder (depression etc.) or sleep disorder (insomnia, sleep apnea syndrome etc.)
6)Night shift or shift workers
7) Excessively irregular lifestyle such as eating or sleeping
8) Participants who is extreme skipped eating
9) Participants who is current disease or history of diabetes, liver disease (hepatitis), kidney disease, serious disease such as heart disease, thyroid disease, adrenal disease, other metabolic diseases
10) Participants who is use health foods, supplements, and medicines that may affect cognitive function
11) Participants who is participated in other human clinical studies within the past 3 months or are expected to participate in other human clinical studies during the study period.
12) Participants who is pregnant, breast-feeding, or willing to become pregnant during the study period
13) Participants who is difficult to comply with the records of various surveys
14) Participants who is judged to be unsuitable as subject from clinical laboratory test value and measurement value at the time of SCR

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Noritaka
Middle name
Last name Okamura

Organization

Ehime Prefectural University of Health Sciences

Division name

Clinical Examination Department

Zip code

791-2101

Address

543 Takoda, Tobe-Cho, Iyo-Gun, Ehime

TEL

089-958-2111

Email

okamu@epu.ac.jp


Public contact

Name of contact person

1st name Yoshitake
Middle name
Last name Baba

Organization

ITO EN, LTD.

Division name

Central Research Institute

Zip code

421-0516

Address

21 mekami, makinohara, shizuoka

TEL

0548-54-1247

Homepage URL


Email

yoshi-baba@itoen.co.jp


Sponsor or person

Institute

ITO EN, LTD.

Institute

Department

Personal name



Funding Source

Organization

ITO EN, LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committees of Ehime Prefectural University of Health Sciences

Address

543 Takoda, Tobe-Cho, Iyo-Gun, Ehime

Tel

089-958-2111

Email

@@@


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 01 Month 10 Day

Date of IRB


Anticipated trial start date

2025 Year 01 Month 20 Day

Last follow-up date

2026 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 12 Month 25 Day

Last modified on

2024 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064644